DBL™ OCTREOTIDE INJECTION - Medsafe
Data Sheet – New Zealand Version 4.0 1 DBL™ OCTREOTIDE INJECTION Name of medicine Octreotide acetate . Presentation . Each 1 mL vial of DBL™ Octreotide Injection is a clear colourless solution, containing 0.05 mg, 0.1 mg or
Download DBL™ OCTREOTIDE INJECTION - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Diabetes in Dogs - Australian Terrier Club of America
australianterrier.orgDiabetes in Dogs Thomas K. Graves, DVM, PhD, DACVIM University of Illinois at Urbana-Champaign
Carcinomas of Unknown Primary Site - PhenoPath
phenopath.com22 © 2013 PhenoPath Laboratories, PLLC. All rights reserved. CARCINOMAS OF UNKNOWN PRIMARY SITE Which antibodies should be run? PhenoPath Laboratories’ pathologists utilize a focused
DRUG NAME: Octreotide - BC Cancer
www.bccancer.bc.caOctreotide BCCA Cancer Drug Manual© Page 1 of 9 Octreotide Developed: 2001 Revised: 1 July 2015 DRUG NAME: Octreotide SYNONYM(S): Octreotide acetate, SMS 201 -995, synthetic octapeptide analogue of somatostatin, SMS LAR
Somatosan 3 mg IV - demilac.com.tr
www.demilac.com.trSomatosan (Somatostatin) 3 mg IV FORMÜL Bir ampul, liyofilize toz şeklinde, 3 mg Somatostatin’e eşdeğer miktarda 3.19 – 3.85 mg arasında
Management of Ileostomy and other GI Fluid Losses
www.downstatesurgery.orgManagement of Ileostomy and other GI Fluid Losses Morbidity and Mortality Conference April 29, 2005 Kings County Hospital Sajani Shah MD
2. Juli 2010 Dr. Gero Steimann – Reha-Zentrum …
www.grvs.deOctreotid Somatostatin-Analogum - Hemmung der Sekretion vieler Hormone, wie Gastrin, Cholezystokinin, PP, TSH, Sekretin, VIP, Insulin, Glukagon
PACKAGE LEAFLET: INFORMATION FOR THE USER …
www.medicines.org.ukPage 1 of 9 PACKAGE LEAFLET: INFORMATION FOR THE USER Somatuline® autogel® 60 mg, solution for injection in a prefilled syringe. Somatuline® autogel® 90 mg, solution for injection in a prefilled syringe.